← ProductsFOXO4 DRI research vial

Longevity Research Compounds

In stock

FOXO4 DRI

Vial size

$149.99

FOXO4-DRI is a cell-permeable peptide designed to antagonize the interaction between FOXO4 and p53 for the investigation of targeted apoptosis in senescent cells, intended for research use only.

Specification

Purity
99%
Vial sizes
10mg / 20 mg
Physical form
Lyophilized powder
Storage
-20°C, protect from light

Certificate of analysis with purity and mass-spec identity confirmation available on request for this lot.

For laboratory research use only. Not for human consumption, diagnosis, or treatment. Not evaluated by the FDA. Purchasers are responsible for compliance with all applicable regulations.